Health Payer Intelligence October 16, 2023
The patient assistance program will maintain financial support for certain populations seeking to access Pfizer’s Paxlovid, starting in 2024.
The Department of Health and Human Services (HHS) will ensure access to a coronavirus therapy from Pfizer for Medicare and Medicaid beneficiaries and the uninsured through a patient assistance program, the department announced.
“This agreement builds on HHS and Pfizer’s strong partnership over the last three years that enabled the development, manufacture, and distribution of COVID-19 vaccines and therapeutics at a record pace,” the press release stated.
According to the agreement, the drug known as Paxlovid will be available to public payer beneficiaries in Medicare and Medicaid as well as the uninsured through the end of 2024. Beneficiaries will not have...
Today's Sponsors
Today's Sponsor